Observational studyBMC infectious diseases2022

Reactogenicity after heterologous and homologous COVID-19 prime-boost vaccination regimens: descriptive interim results of a comparative observational cohort study.

Lisette Warkentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.